The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism
- 30 September 1994
- journal article
- Published by Elsevier BV in Gastroenterology
- Vol. 107 (3), 738-743
- https://doi.org/10.1016/0016-5085(94)90121-x
Abstract
No abstract availableThis publication has 14 references indexed in Scilit:
- Potent inhibitory action of the gastric proton pump inhibitor lansoprazole against urease activity of Helicobacter pylori: unique action selective for H. pylori cellsAntimicrobial Agents and Chemotherapy, 1993
- Effects of omeprazole on neutrophil chemotaxis, super oxide production, degranulation, and translocation of cytochrome b-245.Gut, 1992
- Hypotheses on the pathogenesis and natural history of Helicobacter pylori-induced inflammationGastroenterology, 1992
- Surface proteins from Helicobacter pylori exhibit chemotactic activity for human leukocytes and are present in gastric mucosa.The Journal of Experimental Medicine, 1992
- Helicobacter pyloriInfection and Gastric Carcinoma among Japanese Americans in HawaiiNew England Journal of Medicine, 1991
- OmeprazoleNew England Journal of Medicine, 1991
- Lansoprazole, a novel benzimidazole proton pump inhibitor, and its related compounds have selective activity against Helicobacter pyloriAntimicrobial Agents and Chemotherapy, 1991
- Urea protects Helicobacter (Campylobacter) pylori from the bactericidal effect of acidGastroenterology, 1990
- Helicobacter pylori and the Pathogenesis of Gastroduodenal InflammationThe Journal of Infectious Diseases, 1990
- Energy production in Ureaplasma urealyticumThe Pediatric Infectious Disease Journal, 1986